FindTrial
Sign In

A study to investigate the effect of Nagapheni (Optunia elatior Mill.) in the treatment of anemia.

A Pharmacological and Pharmacotherapeutical evaluation of fruit of Nagapheni (Opuntia elatior Mill.) on Pandu

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/02/005547
Enrollment
60
Registered
2015-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients selected on the basis of the classical symptoms of Pandu(anaemia) and Level of Hb is low to normal value

Interventions

Intervention1: Opuntia elatior Mill.: 0ml swarasa/day with luke warm water duration 2 months follw up 1 month

Sponsors

Institute for post gradute teaching and research in Ayurevda gujarat ayurveda university jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between age of 18-60 yrs Irrespective of sex Diagnosed Pandu as per with classical symptomsHb% below 12gm (F) and below 13gm (M) or reduced RBC count

Exclusion criteria

Exclusion criteria: Age less than 18 years and more than 60 years Pregnancy and lactation Severe Renal Hepatic Cardiac disease Cancer Any continuing blood loss e g Hematemesis Melaena Bleeding piles etc

Design outcomes

Primary

MeasureTime frame
relief in the of symptoms on Pandu(anaemia)like Panduta (Pallor, Panduta (Pallor)etc.Timepoint: Hemoglobin will be estimated after 2 month of trial drug Opuntia elatior Mill.—

Secondary

MeasureTime frame
relief in Shrama (Fatigue), Shwasa (Exertional Dyspnoea) etc.Timepoint: upto present study—

Countries

India

Contacts

Public ContactPrajapati Shashikant

I P G T and R A GAU Jamnagar

drrnacharya@gmail.com9924585855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026